Free Screenings

Why do I need to be screened?

1 in 3 Americans have Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), also known as fatty liver disease, or Metabolic Dysfunction-Associated Steatohepatitis (MASH), and many of them may not know it. We use Fibroscan (aka Liver Scans) as an alternative to liver biopsy to detect and stage fatty liver disease. It is an ultrasound-based imaging tool that captures liver stiffness and scarring caused by fatty deposits in the liver.

Fibroscan is painless, non-invasive, requires no sedation, and can be done in as little as a few minutes which allows our providers to diagnose a patient’s condition during their visit.

What is a FibroScan?®

A FibroScan is a quick, non-invasive liver examination similar to an ultrasound.  It uses vibration-controlled transient elastography technology to assess liver health.  The procedure takes about 10 minutes and delivers instant results.

Who Should Consider a FibroScan?

Individuals with any of the following risk factors may have a higher likelihood of developing fatty liver disease.  Since fatty liver disease often has no symptoms, understanding these risk factors is essential for determining who should be screened.

  • Obesity
  • Diabetes
  • Age over 50
  • High Cholesterol
  • High Blood Pressure (Hypertension)
  • Hispanic Ethnicity
  • BMI over 30

Important Words to Know Before Reading Your Results

  • Cap Score: The amount of fat inside the liver cells
  • Liver Fibrosis: Formation of an abnormally large amount of scar tissue in the liver
  • Metabolic dysfunction-associated steatotic liver disease (MASLD): This new term replaces nonalcoholic fatty liver disease (NAFLD) and refers to patients who have fat accumulation in the liver (steatosis) along with at least one metabolic risk factor such as overweight/obesity, high blood pressure, type 2 diabetes, or abnormal cholesterol or triglyceride levels.
  • ALT/AST Levels: Enzymes in the liver that can indicate liver damage when elevated
  • Cirrhosis: Advanced scarring of the liver, often due to long-term liver damage.
  • Liver Stiffness: A measurement that indicates how stiff or firm the liver is, often related to fibrosis.
  • Steatosis: The presence of fat in the liver.

FIBROSCAN is approved by the US Food and Drug Administration (FDA) to diagnose liver disease.

This error message is only visible to WordPress admins
Error: The stored access token could not be decrypted on this site. Feed will not update.